Drugmaker Roche’s US Biotech Unit Pulls DEI Targets From Website

Roche Holding AG’s US unit removed diversity and inclusion targets from its website, the latest in a series of publicly traded companies to bow to US President Donald Trump’s push against equal opportunity programs.

Genentech had aimed by this year to double Black and Hispanic representation of directors and officers and extended leadership, among a range of commitments listed on reports and a version of its diversity website archived by the Wayback Machine.

The biotech unit also pledged to craft inclusive research action plans for all medicines in development and require commitments from suppliers with requests for proposals ...